Amanda C Doran
Overview
Explore the profile of Amanda C Doran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
2552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeppesen D, Sanchez Z, Kelley N, Hayes J, Ambroise J, Koory E, et al.
Nat Cell Biol
. 2025 Feb;
27(3):438-448.
PMID: 39984653
Cells secrete a large variety of extracellular vesicles (EVs) to engage in cell-to-cell and cell-to-environment intercellular communication. EVs are functionally involved in many physiological and pathological processes by interacting with...
2.
Wassenaar J, Smart C, Fehrenbach D, Agrawal V, Dungan M, Fortune N, et al.
JACC Basic Transl Sci
. 2025 Feb;
10(1):107-109.
PMID: 39958476
No abstract available.
3.
Kohutek Z, Caslin H, Fehrenbach D, Heimlich J, Brown J, Madhur M, et al.
Circ Res
. 2025 Jan;
136(3):325-353.
PMID: 39883790
Cardiovascular and cardiometabolic diseases are leading causes of morbidity and mortality worldwide, driven in part by chronic inflammation. Emerging research suggests that the bone marrow microenvironment, or marrow niche, plays...
4.
Semler E, Michell D, Kingsley P, Massick C, Ramirez M, Castleberry M, et al.
bioRxiv
. 2025 Jan;
PMID: 39763941
Epitranscriptomic modifications on RNA play critical roles in stability, processing, and function, partly by influencing interactions with RNA-binding proteins and receptors. The role of post-transcriptional RNA modifications on cell-free non-coding...
5.
Antonetti O, Desine S, Smith H, Robles M, McDonald E, Ovide G, et al.
Nutr Metab Cardiovasc Dis
. 2024 Apr;
34(7):1712-1720.
PMID: 38658223
Background And Aims: The cardiometabolic disease-associated metabolite, alpha-aminoadipic acid (2-AAA) is formed from the breakdown of the essential dietary amino acid lysine. However, it was not known whether elevated plasma...
6.
Obare L, Bonami R, Doran A, Wanjalla C
J Cell Physiol
. 2024 Apr;
239(6):e31270.
PMID: 38651687
Atherosclerosis remains a leading cause of cardiovascular disease (CVD) globally, with the complex interplay of inflammation and lipid metabolism at its core. Recent evidence suggests a role of B cells...
7.
Pimenov L, Gonzalez A, Doran A, Knapp S
Genes Immun
. 2024 Apr;
25(3):264.
PMID: 38594516
No abstract available.
8.
Pimenov L, Gonzalez A, Doran A, Knapp S
Genes Immun
. 2024 Jan;
25(1):1-3.
PMID: 38245600
No abstract available.
9.
Desine S, Gabriel C, Smith H, Antonetti O, Wang C, Calcutt M, et al.
Front Endocrinol (Lausanne)
. 2023 Sep;
14:1122391.
PMID: 37745703
Introduction: Plasma levels of the metabolite alpha-aminoadipic acid (2-AAA) have been associated with risk of type 2 diabetes (T2D) and atherosclerosis. However, little is known about the relationship of 2-AAA...
10.
Zarrow J, Alli-Oluwafuyi A, Youwakim C, Kim K, Jenkins A, Suero I, et al.
ACS Chem Biol
. 2023 Aug;
18(8):1891-1904.
PMID: 37531659
-Acyl-phosphatidylethanolamine hydrolyzing phospholipase D (NAPE-PLD) is a zinc metallohydrolase that hydrolyzes -acyl-phosphatidylethanolamines (NAPEs) to form -acyl-ethanolamines (NAEs) and phosphatidic acid. Several lines of evidence suggest that reduced NAPE-PLD activity could...